- Report
- June 2025
Europe
From €1900EUR$2,095USD£1,600GBP
€3618EUR$3,990USD£3,047GBP
- Report
- June 2025
Global
From €1900EUR$2,095USD£1,600GBP
€3618EUR$3,990USD£3,047GBP
From €1900EUR$2,095USD£1,600GBP
€3618EUR$3,990USD£3,047GBP
- Report
- June 2025
United States
From €1900EUR$2,095USD£1,600GBP
€3618EUR$3,990USD£3,047GBP
- Report
- June 2025
North America
From €1900EUR$2,095USD£1,600GBP
€3618EUR$3,990USD£3,047GBP
- Report
- June 2025
Middle East
From €1900EUR$2,095USD£1,600GBP
€3618EUR$3,990USD£3,047GBP
- Report
- June 2025
Asia Pacific
From €1900EUR$2,095USD£1,600GBP
€3618EUR$3,990USD£3,047GBP
- Report
- February 2025
- 86 Pages
Brazil, China, India, ... Brazil, China, India, Russia
From €5436EUR$5,995USD£4,579GBP
- Report
- February 2025
- 103 Pages
Asia Pacific
From €5436EUR$5,995USD£4,579GBP
- Report
- February 2025
- 29 Pages
Mexico
From €4529EUR$4,995USD£3,815GBP
- Report
- February 2025
- 29 Pages
Brazil
From €4529EUR$4,995USD£3,815GBP
- Report
- February 2025
- 29 Pages
Japan
From €4529EUR$4,995USD£3,815GBP
- Report
- February 2025
- 29 Pages
China
From €4529EUR$4,995USD£3,815GBP
- Report
- February 2025
- 30 Pages
South Korea
From €4529EUR$4,995USD£3,815GBP
- Report
- February 2025
- 29 Pages
Russia
From €4529EUR$4,995USD£3,815GBP
- Report
- February 2025
- 31 Pages
Spain
From €4529EUR$4,995USD£3,815GBP
- Report
- February 2025
- 29 Pages
Italy
From €4529EUR$4,995USD£3,815GBP
- Report
- February 2025
- 29 Pages
France
From €4529EUR$4,995USD£3,815GBP
- Report
- February 2025
- 29 Pages
United Kingdom
From €4529EUR$4,995USD£3,815GBP
- Report
- February 2025
- 30 Pages
United States
From €4529EUR$4,995USD£3,815GBP

The Infusions and Injectables market is a segment of the pharmaceutical industry that focuses on the production and distribution of drugs that are administered through intravenous (IV) or intramuscular (IM) injections. These drugs are used to treat a variety of medical conditions, including cancer, diabetes, and autoimmune diseases. The market is highly competitive, with a number of large pharmaceutical companies vying for market share.
The market is divided into two main segments: branded and generic drugs. Branded drugs are typically more expensive than generic drugs, but they are often more effective and have fewer side effects. Generic drugs are typically cheaper, but they may not be as effective or have as many side effects.
Some of the major players in the Infusions and Injectables market include Pfizer, Merck, Novartis, Sanofi, and Johnson & Johnson. These companies are responsible for the production and distribution of a wide range of drugs, including cancer treatments, diabetes medications, and autoimmune therapies. Show Less Read more